In CRC, Tumor–Fibroblast interactions showed enrichment in ‘Epithelial Mesenchymal Transition (EMT)’, ‘ECM–receptor interaction’, ‘Collagen receptor activity’, and ‘Extracellular matrix organization’, all of which are representative of cancer-associated fibroblast activation pathways. The gene discussed is ITGA2; the disease is cancer.